Use of pyridine-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin

Details for Australian Patent Application No. 2004222051 (hide)

Owner Pierre Fabre Medicament

Inventors Colpaert, Francis; Vacher, Bernard

Agent Freehills

Pub. Number AU-B-2004222051

PCT Pub. Number WO2004/083171

Priority 03/03099 13.03.03 FR

Filing date 15 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 15 January 2009

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/083171 Priority application(s): WO2004/083171

3 November 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of pyridine2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin

15 January 2009 Application Accepted

  Published as AU-B-2004222051

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222059-Improvements in and relating to trailer coupling

2004222044-7-imino derivatives of camptothecin having antitumor activity